ES8608872A1 - Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada. - Google Patents

Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.

Info

Publication number
ES8608872A1
ES8608872A1 ES536167A ES536167A ES8608872A1 ES 8608872 A1 ES8608872 A1 ES 8608872A1 ES 536167 A ES536167 A ES 536167A ES 536167 A ES536167 A ES 536167A ES 8608872 A1 ES8608872 A1 ES 8608872A1
Authority
ES
Spain
Prior art keywords
endotoxin
extract
pyridine
treatment
piridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536167A
Other languages
English (en)
Spanish (es)
Other versions
ES536167A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ES536167A0 publication Critical patent/ES536167A0/es
Publication of ES8608872A1 publication Critical patent/ES8608872A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES536167A 1983-09-23 1984-09-21 Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada. Expired ES8608872A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
ES536167A0 ES536167A0 (es) 1986-07-16
ES8608872A1 true ES8608872A1 (es) 1986-07-16

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536167A Expired ES8608872A1 (es) 1983-09-23 1984-09-21 Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.

Country Status (23)

Country Link
US (1) US4663306A (cg-RX-API-DMAC10.html)
JP (1) JPS60120817A (cg-RX-API-DMAC10.html)
KR (1) KR870000843B1 (cg-RX-API-DMAC10.html)
AT (1) AT385659B (cg-RX-API-DMAC10.html)
AU (1) AU566234B2 (cg-RX-API-DMAC10.html)
BE (1) BE900650A (cg-RX-API-DMAC10.html)
CA (1) CA1244765A (cg-RX-API-DMAC10.html)
CH (1) CH664897A5 (cg-RX-API-DMAC10.html)
DE (1) DE3434766C2 (cg-RX-API-DMAC10.html)
DK (1) DK446684A (cg-RX-API-DMAC10.html)
ES (1) ES8608872A1 (cg-RX-API-DMAC10.html)
FI (1) FI843716A7 (cg-RX-API-DMAC10.html)
FR (1) FR2552326B1 (cg-RX-API-DMAC10.html)
GB (1) GB2149301B (cg-RX-API-DMAC10.html)
HU (1) HU192585B (cg-RX-API-DMAC10.html)
IL (1) IL73034A (cg-RX-API-DMAC10.html)
IN (1) IN157240B (cg-RX-API-DMAC10.html)
IT (1) IT1179444B (cg-RX-API-DMAC10.html)
NL (1) NL8402902A (cg-RX-API-DMAC10.html)
NO (1) NO843776L (cg-RX-API-DMAC10.html)
NZ (1) NZ209635A (cg-RX-API-DMAC10.html)
SE (1) SE8404707L (cg-RX-API-DMAC10.html)
ZA (1) ZA847405B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
ATE210989T1 (de) * 1993-08-27 2002-01-15 Vetrepharm Inc Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
BR9815602A (pt) 1997-08-05 2001-12-11 Bioniche Inc Composição e processo para induzir uma respostaem células sensìveis de um animal para tratar umcancer
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
CA2337445A1 (en) 1998-07-16 2000-01-27 Sumitomo Pharmaceuticals Co., Ltd. Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
DE60043759D1 (de) * 1999-12-13 2010-03-11 Bioniche Life Sciences Inc Therapeutisch nützliche synthetische Oligonukleotide
EP1250152B1 (en) * 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Synergistic composition containing hyaluronic acid in the treatment of cancer
LU90996B1 (en) * 2000-07-11 2003-01-08 Bayer Ag Use of the strains of the parapox ovis virus against fibrosis
CN100482275C (zh) * 2002-03-05 2009-04-29 细胞医药股份有限公司 固化的组织免疫佐剂
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
WO2005023277A1 (fr) * 2003-09-05 2005-03-17 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
KR102039520B1 (ko) 2013-04-18 2019-11-01 이뮨 디자인 코포레이션 암 치료에 이용하기 위한 gla 단일요법
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
HUE071447T2 (hu) 2014-06-17 2025-08-28 Crown Laboratories Inc Genetikailag módosított baktériumok és eljárások baktériumok genetikai módosítására
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
US20210040055A1 (en) * 2017-08-17 2021-02-11 University Of Delaware Furan based compositions and methods of making thereof
WO2021262622A1 (en) 2020-06-23 2021-12-30 Crown Laboratories, Inc. Probiotic skin formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (cg-RX-API-DMAC10.html) * 1972-06-20 1973-12-27
FR2269962B1 (cg-RX-API-DMAC10.html) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
NZ209635A (en) 1989-01-27
DE3434766C2 (de) 1987-05-14
BE900650A (fr) 1985-03-21
JPS60120817A (ja) 1985-06-28
CA1244765A (en) 1988-11-15
HUT35521A (en) 1985-07-29
AU566234B2 (en) 1987-10-15
ATA302384A (de) 1987-10-15
CH664897A5 (de) 1988-04-15
JPS6254775B2 (cg-RX-API-DMAC10.html) 1987-11-17
FI843716L (fi) 1985-03-24
IT1179444B (it) 1987-09-16
FR2552326B1 (fr) 1988-05-13
AT385659B (de) 1988-05-10
ES536167A0 (es) 1986-07-16
IT8448894A0 (it) 1984-09-24
FR2552326A1 (fr) 1985-03-29
KR870000843B1 (ko) 1987-04-25
HU192585B (en) 1987-06-29
KR850002404A (ko) 1985-05-13
US4663306A (en) 1987-05-05
IL73034A (en) 1988-11-15
AU3340084A (en) 1985-03-28
FI843716A7 (fi) 1985-03-24
NO843776L (no) 1985-03-25
ZA847405B (en) 1985-05-29
DE3434766A1 (de) 1986-04-30
GB2149301A (en) 1985-06-12
GB2149301B (en) 1988-06-22
SE8404707L (sv) 1985-03-24
DK446684A (da) 1985-03-24
FI843716A0 (fi) 1984-09-21
IN157240B (cg-RX-API-DMAC10.html) 1986-02-15
GB8423993D0 (en) 1984-10-31
DK446684D0 (da) 1984-09-19
SE8404707D0 (sv) 1984-09-20
NL8402902A (nl) 1985-04-16

Similar Documents

Publication Publication Date Title
ES8608872A1 (es) Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.
ES8101887A1 (es) Procedimiento para obtener una preparacion farmaceutica que comprende un glicorido cardiaco con un revertimiento de po- limero
CN106588665B (zh) 一种脂溶性咖啡酸脂肪酸结构油脂及其制备方法与应用
DE3761093D1 (de) Herstellungsverfahren von aethyltrifluoracetat.
DE3585713D1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
WO2017203498A1 (pt) Processos de extração da cinaropicrina presente nas folhas de cynara cardunculus l.
CH512835A (de) Verfahren zur Herstellung elektrischer Verbindungselemente und zu ihrer Befestigung an elektrischen Leitern sowie Vorrichtung zur Ausführung des Verfahrens
GB724256A (en) Improvements in the production of esters of pyridine carboxylic acids
BE768647A (fr) Procede d'extraction de la fraction insaponifiable de corps gras naturels
GB1427253A (en) Antilipemic composition containing unsaponifiable matter of soybean oil
ES8505665A1 (es) Procedimiento para preparar derivados acilaminofenolicos
ES556273A0 (es) Procedimiento para la separacion y el aislamiento del nosiheptido
SU973128A1 (ru) Способ получени эйкозапентаеновой кислоты
CA937935A (en) Process for the preparation of benzimidazole-2-carbamic acid esters
JPS5242815A (en) Process for preparation of carboxylic acid esters
YOKOKAWA Studies on the Oils of Basidiomycetes. IV. On the Oils of Masutake (Polyporus sulphureus, Fr.) and Kikurage (Auricularia auricula jadae, Quel)
BE770496A (fr) Nouveaux derives bis-phosphoryles utiles notamment comme anthelminthiques et leur procede de preparation
AU438234B2 (en) PROCESS FORTHE PREPARATION OF BENZIMIDAZOLE CARBAMIC acid esters
IT1054501B (it) Processo per la preparazione di esteri del acido i.4 naftalendi carbossilico
BE764837A (fr) Nouveaux esters d'acide phosphorique, leur procede de preparation et leur application comme insectides acaricides et nematocides
CA922572A (en) Method of preparing vegetable concentrate and concentrate thereby produced
JPS5398918A (en) Preparation of gamma-pyrone derivatives
JPS5575401A (en) Polysaccharide and preparation thereof
AU1935970A (en) Process forthe preparation of branched epoxyalkyl esters
Stevan et al. Investigations on Extraction of Rat Plasma Phospholipids.